Background: Prostate cancer is a substantial public health concern; however, in recent
years, national guidelines have recommended against prostate cancer screening. We …

Purpose Prostate biopsy rates have paralleled decreasing prostate specific antigen
screening rates since 2012. We hypothesized that biopsy rates and the change in rates …

Background: Population characteristics associated with the use of prostate biopsy are poorly
understood. We described the use of diagnostic prostate biopsy and subsequent biopsy …

Background Despite the considerable attention given to the prostate-specific antigen (PSA)
as a screening test for prostate cancer, it is needle biopsy—and not the PSA test result—that …

We reviewed the status of prostate cancer diagnosis in Western Australia (WA) with the aim
of improving decision-making about PSA testing and prostate biopsy. Our patient cohort was …

Purpose Uptake of active surveillance and changes in prostate cancer care may affect the
utilization of and complications following prostate needle biopsy. We characterized recent …

Our group recently reported an increasing frequency of hospitalizations after prostate biopsy
[1] consistent with numerous international studies [2, 3]. This subject has important public …

This article assesses the positive biopsy rate and core sampling pattern in patients
undergoing needle biopsy of the prostate in the United States at a national reference …

We report changes in the histopathology of prostate cancer diagnosed in a large urology
group practice after the final United States Preventive Services Task Force (USPSTF) Grade …

Background: The ambivalent results of recent large randomized prostate cancer studies
have added a significant layer of uncertainty for clinicians and patients contemplating …